top of page
Product Page: Stores_Product_Widget

QRP Research KLOW 80mg is a four-peptide research formulation combining BPC-157, TB-500, GHK-Cu and KPV in a single lyophilised research blend.

Each component represents a distinct area of experimental peptide research, encompassing cellular signalling, cytoskeletal dynamics, extracellular matrix biology, copper-dependent pathways and inflammatory-response mechanisms.

The KLOW formulation contains 10mg BPC-157, 10mg TB-500, 50mg GHK-Cu and 10mg KPV, providing a total of 80mg of research material per vial.

This multi-component formulation enables controlled laboratory investigation of several different peptide-associated pathways within a single experimental research system.

BPC-157 Research Profile

BPC-157 is a synthetic 15-amino-acid peptide that has been investigated predominantly in laboratory and preclinical models.

Experimental research has examined BPC-157 in relation to cell migration, vascular signalling, angiogenesis-associated mechanisms, nitric oxide pathways and cellular responses involved in tissue remodelling.

Research has also explored interactions involving VEGF/VEGFR signalling, endothelial-cell behaviour and extracellular matrix-associated processes.

TB-500 Research Profile

TB-500 is a synthetic research peptide associated with the actin-related region of Thymosin Beta-4 (Tβ4).

Actin is a fundamental component of the cellular cytoskeleton and contributes to cell shape, structural organisation, migration, division and motility.

TB-500 and related Thymosin Beta-4-derived peptides have therefore attracted experimental interest in research involving actin dynamics, cytoskeletal organisation, cellular migration and tissue-remodelling mechanisms.

Research involving TB-500 should be distinguished from research involving full-length Thymosin Beta-4, as findings involving the complete parent peptide cannot automatically be attributed to TB-500.

GHK-Cu Research Profile

GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding tripeptide consisting of glycine, histidine and lysine (Gly-His-Lys) complexed with copper.

GHK-Cu has been extensively investigated in experimental models involving copper-dependent cellular signalling, extracellular matrix biology, collagen-associated mechanisms and gene-expression regulation.

Scientific research has also examined its relationship with fibroblast activity, extracellular matrix components, metalloproteinases, oxidative processes and cellular remodelling mechanisms.

Its ability to bind copper makes GHK-Cu particularly interesting for investigating the relationship between trace-metal homeostasis and peptide-mediated cellular signalling.

KPV Research Profile

KPV (Lys-Pro-Val) is a short tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH).

KPV has attracted experimental interest because research has examined its relationship with inflammatory signalling, immune-response pathways and epithelial biology.

Laboratory and preclinical research has investigated KPV in connection with signalling mechanisms involving pro-inflammatory mediators, cellular immune responses and barrier-associated biological processes.

Its compact three-amino-acid structure also makes KPV an interesting research model for investigating how short peptide sequences derived from larger regulatory peptides can retain distinct biological signalling properties.

Multi-Peptide Research

KLOW combines four structurally and biologically distinct research peptides associated with different but potentially intersecting experimental pathways.

BPC-157 research has focused substantially on cellular and vascular signalling mechanisms.

TB-500-related research has examined actin-associated cytoskeletal processes and cellular migration.

GHK-Cu provides a separate research dimension involving copper-dependent signalling, extracellular matrix biology and gene regulation.

KPV introduces an additional area of investigation involving inflammatory-response and peptide-mediated immune signalling pathways.

This combination makes KLOW particularly relevant for controlled experimental investigation of interactions between:

  • Cellular migration and motility
  • Cytoskeletal and actin dynamics
  • Extracellular matrix regulation
  • Fibroblast-associated mechanisms
  • Collagen-related pathways
  • Angiogenesis-associated signalling
  • Endothelial-cell biology
  • VEGF / VEGFR-related mechanisms
  • Copper-dependent peptide signalling
  • Inflammatory-response pathways
  • Immune-associated cellular signalling
  • Epithelial and barrier-associated biology
  • Gene-expression regulation
  • Oxidative and cellular stress mechanisms
  • Cellular remodelling pathways

The four components have different molecular structures, research histories and proposed mechanisms. Findings involving BPC-157, TB-500, GHK-Cu or KPV individually should therefore not automatically be interpreted as demonstrating additive or synergistic effects of the combined KLOW formulation.

 

Product Specification

Product: KLOW
Compounds: BPC-157 / TB-500 / GHK-Cu / KPV
Compound Type: Multi-Peptide Research Blend

BPC-157: 10mg
TB-500: 10mg
GHK-Cu: 50mg
KPV: 10mg
Total Content: 80mg per vial

Form: Lyophilised research material
Primary Research Areas: Cellular Signalling / Cytoskeletal Biology / Extracellular Matrix Research / Copper-Peptide Biology / Inflammatory Signalling
Brand: QRP Research
Application: Laboratory and scientific research

 

Storage

Store in a cool, dry and dark environment, protected from excessive heat, direct light and moisture.

Appropriate laboratory storage procedures should be followed to preserve the stability and integrity of the research material.

Research Use Notice

FOR RESEARCH USE ONLY.

This product is supplied exclusively for laboratory, analytical and scientific research.

  • NOT for human consumption or administration.
  • NOT for animal consumption or administration.
  • NOT a medicine, food supplement or cosmetic product.
  • NOT intended to diagnose, treat, cure or prevent any disease.
  • No human dosing or administration instructions are provided.
  • Intended to be handled only by appropriately qualified researchers or laboratory professionals.

QRP Research KLOW 80mg is supplied strictly as a research material for non-clinical laboratory investigation.

QRP Research KLOW 80mg

No reviews
£60.00 Regular Price
£51.00Sale Price

Spend More, Get More

Quantity
    No Reviews YetShare your thoughts. Be the first to leave a review.

    Related Products

    bottom of page
    QRP Research Confidence Score on Peptide Supermarket